A61P 31/10
Antimycotics
A61P31/10 (Antimycotics) appears on 6,630 US grants and 9,843 published applications in this corpus.
Search patents in A61P- Granted patents
- 6,630
- Published applications
- 9,843
- Assignees
- 3,688
- Inventors
- 16,984
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 7 | 0 |
| 1981 | 11 | 0 |
| 1982 | 8 | 0 |
| 1983 | 7 | 0 |
| 1984 | 6 | 0 |
| 1985 | 6 | 0 |
| 1986 | 8 | 0 |
| 1987 | 9 | 0 |
| 1988 | 8 | 0 |
| 1989 | 17 | 0 |
| 1990 | 20 | 0 |
| 1991 | 13 | 0 |
| 1992 | 25 | 0 |
| 1993 | 15 | 0 |
| 1994 | 27 | 0 |
| 1995 | 20 | 0 |
| 1996 | 36 | 0 |
| 1997 | 46 | 0 |
| 1998 | 68 | 0 |
| 1999 | 85 | 0 |
| 2000 | 101 | 0 |
| 2001 | 141 | 54 |
| 2002 | 148 | 186 |
| 2003 | 150 | 341 |
| 2004 | 113 | 426 |
| 2005 | 132 | 456 |
| 2006 | 168 | 392 |
| 2007 | 140 | 409 |
| 2008 | 167 | 481 |
| 2009 | 162 | 508 |
| 2010 | 269 | 696 |
| 2011 | 282 | 672 |
| 2012 | 410 | 749 |
| 2013 | 426 | 489 |
| 2014 | 475 | 545 |
| 2015 | 381 | 453 |
| 2016 | 359 | 395 |
| 2017 | 332 | 389 |
| 2018 | 267 | 341 |
| 2019 | 297 | 398 |
| 2020 | 251 | 307 |
| 2021 | 233 | 265 |
| 2022 | 153 | 224 |
| 2023 | 157 | 207 |
| 2024 | 312 | 171 |
| 2025 | 103 | 187 |
| 2026 | 46 | 102 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating fungal infections6 Oct 2026US 12,751,944 B2Neoculi Pty Ltd
- Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)25 Aug 2026US 12,714,745 B2Baylor Research Institute
- Compositions for disrupting biofilm formation and for treating biofilm-related disorders18 Aug 2026US 12,708,612 B2AHV International B.V.
- Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes18 Aug 2026US 12,708,649 B2DermBiont, Inc.
- System for manufacturing coverings for anatomical surfaces18 Aug 2026US 12,712,056 B2H3Alth Technologies Inc.
- Materials and methods for treating fungal infections8 Oct 2026US 2026/0306425 A1Virginia Tech Intellectual Properties, Inc.
- Probiotic compositions and their use in the prevention and/or treatment of oral cavity pathologies and/or disorders8 Oct 2026US 2026/0306565 A1Synbalance Srl
- Biologically compatible, biofilm disrupting composition and methods1 Oct 2026US 2026/0294861 A1
- Substituted pyrimidinone and azapyrimidinone compounds, compositions, and uses thereof1 Oct 2026US 2026/0297118 A1
- Tri-azole antifungal compositions24 Sep 2026US 2026/0283950 A1
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Medical device intended to come into contact with a patient's tissue and related manufacturing method849US 8,753,664 B2Perouse Medical · 2014
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003